Latest Breaking News On - Ntibody drug conjugate mytx 011 - Page 1 : comparemela.com

Alexander I. Spira, MD, PhD, FACP, discusses a phase 1 study of the antibody-drug conjugate MYTX-011 in patients with non–small cell lung cancer.

United statesAlexanderi spiraJohns hopkins school of medicinePhasei programVirginia cancer specialists research instituteJohns hopkins schoolLung cancerOnclive tvNtibody drug conjugate mytx 011Non small cell lung cancer